Thrombin receptor-dependent prostaglandin E-2 synthesis in hamster fibroblasts: Synergistic interactions with interleukin-1 beta

被引:9
作者
Derian, CK
Eckardt, AJ
机构
[1] Drug Discovery, R. W. Johnson Pharmaceutical Res. I., Spring House
[2] R.W. Johnson Pharmaceutical Res. I., Spring House, PA 19477, Welsh and McKean Roads
关键词
D O I
10.1006/excr.1997.3483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cellular responses to alpha-thrombin are mediated through a G-protein-coupled receptor that undergoes proteolytic cleavage, unveiling a tethered peptide ligand with the amino-terminal sequence SFLLRN. The synthetic peptide SFLLRN can mimic many of thrombin's actions via directly stimulating the thrombin receptor. Thrombin has been implicated in several cellular events associated with tissue injury, including fibroblast growth, matrix deposition, and inflammatory responses. The role of the thrombin receptor in fibroblast-dependent release of the inflammatory mediator prostaglandin E-2 was evaluated and compared to its well-characterized effect on cell proliferation. Both thrombin and SFLLRN stimulated [H-3]thymidine incorporation into DNA but failed to induce prostaglandin E-2 release from CCL39 cells. The inflammatory cytokine interleukin-1 beta synergized with thrombin and SFLLRN to induce the release of prostaglandin E-2, whereas it had no effect on thrombin receptor-mediated DNA synthesis. Interleukin-1 beta had no direct effects on thrombin receptor-mediated phosphoinositide hydrolysis, suggesting that its effects were downstream from early signal transduction events. Thrombin and interleukin-1 beta together significantly increased the expression of prostaglandin H synthase-2 in accordance with the prostaglandin E-2 results. These studies indicate that the fibroblast thrombin receptor differentially couples to intracellular signaling pathways leading to distinct functional responses and that thrombin receptor-effector interactions could be modulated by interleukin-1 beta. (C) 1997 Academic Press.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 47 条
[1]  
ALBRIGHTSON CR, 1985, J IMMUNOL, V135, P1872
[2]   CHARACTERIZATION OF PROSTACYCLIN SYNTHESIS IN CULTURED HUMAN ARTERIAL SMOOTH-MUSCLE CELLS, VENOUS ENDOTHELIAL-CELLS AND SKIN FIBROBLASTS [J].
BAENZIGER, NL ;
BECHERER, PR ;
MAJERUS, PW .
CELL, 1979, 16 (04) :967-974
[3]  
BERNHEIM HA, 1985, BRIT J RHEUMATOL, V24, P122
[4]   MODULATION OF ALVEOLAR MACROPHAGE DRIVEN FIBROBLAST PROLIFERATION BY ALTERNATIVE MACROPHAGE MEDIATORS [J].
BITTERMAN, PB ;
WEWERS, MD ;
RENNARD, SI ;
ADELBERG, S ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (03) :700-708
[5]   Ligand cross-reactivity within the protease-activated receptor family [J].
Blackhart, BD ;
Emilsson, K ;
Nguyen, D ;
Teng, W ;
Martelli, AJ ;
Nystedt, S ;
Sundelin, J ;
Scarborough, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16466-16471
[6]   CONDITIONS WHICH AFFECT INITIATION OF ANIMAL-CELL DIVISION BY TRYPSIN AND THROMBIN [J].
CARNEY, DH ;
GLENN, KC ;
CUNNINGHAM, DD .
JOURNAL OF CELLULAR PHYSIOLOGY, 1978, 95 (01) :13-22
[7]   MITOGENIC ACTIVITY OF BLOOD COMPONENTS .1. THROMBIN AND PROTHROMBIN [J].
CHEN, LB ;
BUCHANAN, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (01) :131-135
[8]  
CHIOU WJ, 1990, J IMMUNOL, V145, P2155
[9]  
DAWES KE, 1993, EUR J CELL BIOL, V61, P126
[10]  
DINARELLO CA, 1991, BLOOD, V77, P1627